文献速递生殖医学

RNA修饰在女性生殖生理与疾病中的作用:新兴角色与临床意义

RNA modifications in female reproductive physiology and disease: emerging roles and clinical implications.
PubMed 文献 · Hum Reprod Update · 2025-01-01

本综述基于PubMed近二十年文献,总结RNA修饰(如表观转录组)在女性生殖生物学中的作用,涵盖m6A、A-I编辑、m5C和ac4C等修饰。文章指出这些修饰参与卵泡发生、卵母细胞成熟、受精和胚胎发育,其失调可能与POI、PCOS和子宫内膜异位症等不孕相关疾病有关,并探讨其作为诊断标志物和治疗靶点的潜力。

要点

  • RNA修饰通过writer、eraser和reader蛋白调控基因表达,影响卵泡发生、卵母细胞成熟和胚胎发育。
  • m6A、A-I编辑、m5C和ac4C等修饰的失调可能与POI、PCOS和子宫内膜异位症等不孕相关疾病有关。
  • RNA修饰有潜力作为诊断生物标志物和治疗靶点,但临床研究仍处于早期阶段。

核心结论

  • RNA修饰是生殖生物学中一个变革性领域,高通量测序技术的进步使对表观转录组的理解迅速增长。
  • RNA修饰的失调可能加重不孕相关疾病,如POI、PCOS和子宫内膜异位症。
  • 尽管临床研究仍处于早期阶段,RNA修饰作为诊断生物标志物和治疗靶点显示出巨大前景,有望改善生育和生殖健康结局。

研究设计与样本

  • 本综述通过PubMed检索近二十年同行评议的原创研究和综述,关键词包括RNA修饰相关术语(如m6A、ac4C、A-I编辑)与女性生殖相关术语(如卵巢、卵母细胞、胚胎)的组合。

主要发现

  • 敲除动物模型已鉴定出一系列参与哺乳动物生殖过程的RNA修饰,包括mRNA中常见的m6A、A-I编辑,以及程度较低的m5C和ac4C。
  • 这些调控机制影响多种生殖功能,包括卵泡发生、卵母细胞成熟、受精和胚胎发育。
  • RNA修饰的失调可能加重不孕相关疾病,如POI、PCOS和子宫内膜异位症。

临床怎么用

  • 本综述强调RNA修饰在不孕相关疾病中的临床相关性,并识别出可能影响未来临床决策和个性化治疗的潜在生物标志物及RMP靶向疗法。
  • 这些见解对生殖临床医生和胚胎学家至关重要,为生殖医学的诊断和治疗干预提供了新途径。

局限性

  • 临床研究仍处于早期阶段。
  • 敲除动物模型鉴定的参与哺乳动物生殖过程的RNA修饰列表仍不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: RNA modifications, collectively known as the epitranscriptome, represent the third layer of gene regulation, influencing gene expression at transcriptional, post-transcriptional, and translational levels. RNA-modifying proteins (RMPs), including writers, erasers, and readers, are responsible for depositing, removing, and recognizing chemical modifications on RNA molecules. These modifications play a crucial role in linking molecular processes to cellular functions. Over the past few decades, a growing body of laboratory evidence, alongside advances in sequencing technologies, has uncovered connections between aberrant RNA modifications and reproductive disorders, highlighting their emerging roles in female fertility. Given the rapid expansion of epitranscriptomic research in female reproduction, a comprehensive review is needed to summarize the broader impacts of various RNA modifications, rather than focusing on individual RNA modifications alone. OBJECTIVE AND RATIONALE: This review aims to elucidate the progress in understanding the role of RNA modifications in reproductive biology and how their dysregulations contribute to infertility-related conditions, such as polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), and endometriosis. Special focus will be given to RNA modifications in coding RNAs, particularly those linked to female fertility and supported by solid evidence. The ultimate objective is to explore how targeting the RNA-modification machinery can lead to the development of novel therapeutic interventions for restoring fertility. SEARCH METHODS: We conducted a thorough review of peer-reviewed original research articles and reviews published over the past two decades using the PubMed search engine. Keywords included terms related to RNA modifications, such as 'N6-methyladenosine (m6A)', 'N4-acetylcytidine (ac4C)', and 'adenosine-to-inosine (A-I) editing', combined with terms related to female reproduction, such as 'ovary', 'oocyte', and 'embryo'. Additional relevant search phrases were also utilized to ensure comprehensive coverage of the topic. OUTCOMES: RNA modification has emerged as a transformative area in reproductive biology, with our understanding of the epitranscriptome growing rapidly due to significant advances in high-throughput sequencing technologies. Regulatory proteins play a crucial role in the correct deposition and functional implementation of RNA modifications. Knockout animal models have identified a broad, though still incomplete, list of RNA modifications involved in mammalian reproductive processes. These include prevalent modifications in mRNA, such as m6A, as well as A-I editing, and, to a lesser extent, 5-methylcytosine (m5C) and ac4C. These regulatory mechanisms impact various reproductive functions, including folliculogenesis, oocyte maturation, fertilization, and embryo development. Dysregulation of RNA modifications may exacerbate infertility-related conditions, such as POI, PCOS, and endometriosis. Although clinical investigations are still in their early stages, RNA modifications show great promise as diagnostic biomarkers and therapeutic targets, with the potential to improve fertility and reproductive health outcomes. WIDER IMPLICATIONS: This review explores a relatively underexamined area of epitranscriptomic research in female reproduction, offering the potential to significantly advance our understanding of reproductive biology. It underscores the clinical relevance of RNA modifications in infertility-related disorders and identifies potential biomarkers, as well as RMP-targeted therapies, that could shape future clinical decision-making and personalized treatments. These insights are crucial for reproductive clinicians and embryologists, presenting new avenues for diagnosis and therapeutic interventions in reproductive medicine. REGISTRATION NUMBER: N/A.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Xiang Y, Chang HM, Leung PCK, et al. RNA modifications in female reproductive physiology and disease: emerging roles and clinical implications. Hum Reprod Update. 2025. PMID: 40152541. doi:10.1093/humupd/dmaf005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。